/Viatris%20Inc%20logo%20on%20building-by%20SSKH-Pictures%20via%20Shutterstock.jpg)
Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, operates as a healthcare company. With a market cap of $10.3 billion, the company produces medicines for patients across a broad range of major therapeutic areas spanning both noncommunicable and infectious diseases.
Shares of this global healthcare giant have considerably underperformed the broader market over the past year. VTRS has declined 24.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 18.4%. In 2025, VTRS stock is down 28.2%, compared to the SPX’s 7.6% rise on a YTD basis.